Skeletal muscle derived stem cells for myocardial repair

Keyphrases

• Acute Phase 50%
• Adult Cardiomyocytes 50%
• Cardiac Phenotype 50%
• Cell Death 50%
• Cell Therapy 100%
• Clinical Setting 50%
• Contractile Function 50%
• Donor Cells 50%
• Engraftment 50%
• Genetic Manipulation 50%
• Graft Failure 50%
• Heart Cell 100%
• Infarcted Heart 50%
• Intrinsic Repair 50%
• Left Ventricular Function 50%
• Muscle Stem Cell (MuSC) 100%
• Myoblast 50%
• Myocardial Infarction 50%
• Myocardial Repair 100%
• Myocytes 50%
• Patent Review 50%
• Patients with Heart Failure 50%
• Pharmacological Manipulation 50%
• Phase I Clinical Trial 50%
• Phase II Clinical Trial 50%
• Plethora 50%
• Proliferative Activity 50%
• Recent Patents 50%
• Repair Method 50%
• Resident Stem Cells 50%
• Scar Area 50%
• Skeletal muscle 100%
• Therapeutic Challenges 50%
• Therapeutic Efficacy 50%
• Therapeutic Potential 50%
• Transplantation 50%
• Ventricular Arrhythmia 50%

Medicine and Dentistry

• Cardiac Muscle Cell 50%
• Cell Death 50%
• Cell Therapy 100%
• Clinical Study 50%
• Clinical Trial 50%
• Combination Therapy 50%
• Contractile Function 50%
• Engraftment 50%
• Graft Failure 50%
• Heart Failure 50%
• Heart Ventricle Arrhythmia 50%
• Myoblast 50%
• Myocardial Infarction 50%
• Skeletal Muscle 100%
• Stem Cell 100%

Pharmacology, Toxicology and Pharmaceutical Science

• Clinical Trial 100%
• Combination Therapy 100%
• Graft Failure 100%
• Heart Failure 100%
• Heart Infarction 100%
• Heart Ventricle Arrhythmia 100%
• Preclinical Study 100%